Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Surface Logix achieves objectives with SLx-4090 in phase IIa trial

Jan. 31, 2008

Neose discontinues NE-180 program

Jan. 30, 2008

Generex receives Ukrainian approval for phase III clinical trial of Generex Oral-lyn

Jan. 30, 2008

HIF prolyl hydroxylase inhibitors for anemia prepared and tested at GSK

Jan. 30, 2008

Amgen reports positive results from study of denosumab in osteoporosis

Jan. 29, 2008

TransTech acquires three metabolic disorder programs from Novo Nordisk

Jan. 29, 2008

Novel treatment option for lipoprotein disorders disclosed in recent Roche patent

Jan. 29, 2008

New antidiabetic agents described in patent literature

Jan. 29, 2008

Cannabidiol arrests onset and progression of autoimmune diabetes in mice

Jan. 29, 2008

Kirin Pharma launches Regpara tablets for secondary hyperparathyroidism

Jan. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...